Crude transforming growth factor preparations of placenta contain a polypeptide that is required for the activity of a protein kinase that has been purified from plasma membrane preparations of Ehrlich ascites tumor cells. The kinase activator has been separated from transforming growth factor f3 by reversed-phase HPLC and affinity chromatography. Like the transforming growth factor, it is heat stable and trypsin labile, but it is not inactivated by dithiothreitol. In sodium dodecyl sulfate/polyacrylamide gel electrophoresis the purified preparation shows a major double band at about 31,000 daltons. Comparisons of electrophoretic mobility, protein kinase stimulatory activity, and cross-reactivity with an antibody against histone 1 suggest that the placental activator is identical with histone 1.
31,000 daltons. Comparisons of electrophoretic mobility, protein kinase stimulatory activity, and cross-reactivity with an antibody against histone 1 suggest that the placental activator is identical with histone 1.
We have isolated a cAMP-independent protein kinase from plasma membranes of placenta (1) and Ehrlich ascites tumor cells (2) . The enzyme requires a heat-stable and trypsin-labile polypeptide for activity and hence is termed polypeptide-dependent protein kinase (PPdPK). We describe in this paper the isolation and characterization of the activating polypeptide from human term placenta and its probable identity with histone 1. The polypeptide stimulates an enzyme that can be separated and is distinct from other casein kinases that are inhibited by heparin and stimulated by polyamines.
EXPERIMENTAL PROCEDURES Purification of Placental Activator (PA). Human term placentas obtained from a local hospital were extracted according to the procedure described for the preparation of crude transforming growth factor 3 (TGF-pB) (3) . The lyophilized powder (1.7 g) was dissolved in 30 ml of 1 M acetic acid and centrifuged at room temperature at 10,000 x g for 30 min. The supernatant was applied to a 5 x 60 cm Bio-Gel P-100 (Bio-Rad) column (100-200 mesh) that had been equilibrated with 1 M acetic acid. Elution with 3 liters of 1 M acetic acid (50 ml/hr) and collection of 20-ml fractions were performed at room temperature. Aliquots (1 ml) of every other fraction were dried in a Savant Speedovac concentrator. The dried samples were dissolved in 0.5 ml of glass-distilled water, dried, redissolved, and dried again to remove most of the acetic acid. Finally the samples were taken up with 0.2 ml of 20 mM Tris HCl, pH 7.4, and 5 ,ul was tested for activation of PPdPK. The column fractions corresponding to the active fractions were combined and lyophilized. The powder was dissolved in 50 ml of 50 mM sodium acetate, pH 4.5, and centrifuged at 10,000 x g for 30 min and the supernatant (256 mg) was applied to a Tris-Acryl CM (Pharmacia) column 3.7 x 11 cm that had been equilibrated with the same buffer. Aliquots (5 ,ul) from every other fraction were tested, and the active fractions were pooled, dialyzed against two 2-liter batches of 1 M acetic acid for 24 hr, and then lyophilized.
A small fraction (2%) of the lyophilized powder (2.3 mg) was dissolved in 0.1% trifluoroacetic acid and injected into an Altex C-18 reversed-phase column connected to a Beckman 341-P liquid chromatograph and 160 absorbance detector (214 nm). The column, which had been equilibrated with 10% (vol/vol) acetonitrile/0.1% trifluoroacetic acid, was eluted (1.5 ml per min) with a linear gradient with 25-50% acetonitrile/0.1% trifluoroacetic acid. Fractions (2.25 ml)
were collected in silane-treated test tubes, dried, and washed twice with 0.5 ml of distilled water in a Savant Speedovac Concentrator. The samples were finally dissolved in 0.2 ml of 20 mM Tris HCl, pH 7.4, and 5 p.l of each fraction was tested for PPdPK activation. The active fractions were combined and lyophilized. The lyophilized material was suspended in 0.1% trifluoroacetic acid and then reinjected into the HPLC column. Fractions were collected, dried, washed, assayed, and lyophilized as described above.
Casein-Sepharose was prepared as described (4) with CNBr-activated Sepharose 4B (Sigma) and "autoclaved, hydrolyzed, and partially dephosphorylated" whole casein (Sigma). The HPLC-purified material was dissolved in 1 ml of 20 mM Tris HCl, pH 7.4, and allowed to mix end-overend with casein-Sepharose (1 mg of protein per ml of gel) at 4°C for 16 hr. The mixture was poured into an Econocolumn (Bio-Rad) set in a 16-mm Pyrex tube. The column was washed twice at 4°C with 3 bed volumes of 20 mM Tris-HCI, pH 7.4, in an IEC swinging-bucket centrifuge at 1200 rpm for 3 min. The protein was eluted in the same manner consecutively with 2 bed volumes each of 20 mM Tris HCl, pH 7.4, containing 0.2 M, 0.3 M, 0.5 M, and 0.7 M sodium chloride. The fractions were immediately transferred to Eppendorf tubes and 5 ,ul of each fraction was tested for PPdPK activation.
Assay of PA. PPdPK from Ehrlich ascites tumor (EAT) plasma membranes was prepared and assayed as described previously (2 (3), over 400-fold purification was achieved by gel exclusion, ion-exchange, and reversedphase HPLC chromatography, with a recovery of over 60%. The high yield is, however, only apparent because part of the purification can be accounted for by removal of an inhibitor of PPdPK activity. This can be deduced from the increase in total units recovered from the C-18 HPLC and from the casein-Sepharose columns. An inhibitor of PPdPK activity, found in ascites fluid of EAT cells (6) and subsequently observed to be present in all normal tissues tested, will be described elsewhere. A titration of crude and purified PA as activator of PPdPK is shown in Fig. 1 . It can be seen that high concentrations of crude PA inhibited the protein kinase activity and that the maximal stimulation achieved with purified PA was much higher than with crude PA, thus confirming the presence of an inhibitor in the crude preparation.
It can be seen from Fig. 2 that NaDodSO4/PAGE of purified PA revealed the presence of a major component that appeared as a doublet at about 31,000 kDa resembling the appearance of histone 1 in NaDodSO4/PAGE gels. The doublet of histone 1 has been interpreted in terms of a chargeinduced microheterogeneity and the minor impurities as proteolytic degradation products (7) . Different PA and different commercial histone preparations varied considerably with respect to these minor bands. A histone 1 preparation donated by R. J. DeLange was virtually free of these minor peptides.
Properties of PA. PA was heat stable and labile to trypsin, as shown in Table 2 . In addition to excessive retention of the activator by various ion-exchange resins characteristic for histones (8), we observed considerable losses when glass test tubes were used to collect dilute fractions. Silane-treated glass test tubes were therefore used when dilute solutions of PA were collected-e.g., during HPLC. A comparison of the activity of various histones revealed that histone 1 is the best activator of PPdPK and histone 2B and 4 are the weakest (Table 3) . Although purified PPdPK did not phosphorylate PA or histones, it is well known that histones serve as substrates for cAMPdPK. As can be seen from Fig. 3 , the catalytic subunit of cAMPdPK phosphorylated numerous proteins present in fractions during the purification of PA. Purified PA gave a phosphorylation pattern similar to that of Biochemistry: Abdel-Ghany et aL ed the autophosphorylation of the catalytic subunit. PA from placenta and histone from calf thymus showed cross-reactivity with a rabbit antibody against mouse histone 1 and gave similar patterns of minor bands of proteolytic cross-reacting degradation products (Fig. 4) . Specificity of Enzyme Activation by Polypeptides. Stimulation of protein kinases by histones or polyamines has been observed previously. Miyamoto et al. (10) showed that cAMPdPKs from bovine brain and lobster tail muscle can be activated by using histones instead of cAMP. We have shown (1) that cAMP, as well as many other activators of various protein kinases, have no effect on PPdPK. Feige et al. (11) reported that a protein kinase from the cytosol of bovine adrenal cortex was inhibited by an endogenous inhibitor, which could be replaced by a variety of glycosaminoglycans, including heparin. The inhibition was reversed either by increasing the substrate concentration of casein from 0.75 mg to 7.5 mg/ml or by addition of spertnine. A nuclear protein kinase (N II) from rat hepatoma cells (12) and protein kinases from normal rat liver (13) and tobacco cells (14) were inhibited by heparin. Reticulocytes (15) lane and run in a NaDodSO4/7.5-15% polyacrylamide gel. The gel was dried and exposed to x-ray film (Kodak) for 24 hr. the various casein kinases described in the literature. The most striking one is the hydrophobic nature of PPdPK. The (vol/vol) glycerol, 2% (wt/vol) NaDodSO4, 2% (vol/vol) 2-mercaptoethanol, and 0.1% bromophenol blue at a protein concentration of 1 mg/ml and samples were analyzed by NaDodSO4/12.5% polyacrylamide gel electrophoresis. One gel was stained with Coomassie blue and the proteins on a second were electrotransferred to a nitrocellulose filter. The nitrocellulose filter was decorated with 10 M11 of the antibody against histone 1 and 125I-labeled staphylococcal protein A as previously described (9) . Lanes in A, 5, 10, 
